Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation

INTRODUCTION: IPX203 is a novel oral extended-release (ER) formulation of carbidopa (CD) and levodopa (LD) developed to address the short half-life and limited area for absorption of LD in the gastrointestinal tract. This paper presents the formulation strategy of IPX203 and its relationship to the...

Descripción completa

Detalles Bibliográficos
Autores principales: LeWitt, Peter, Ellenbogen, Aaron, Burdick, Daniel, Gunzler, Steven, Gil, Ramon, Dhall, Rohit, Banisadr, Ghazal, D'Souza, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172697/
https://www.ncbi.nlm.nih.gov/pubmed/37181100
http://dx.doi.org/10.1016/j.prdoa.2023.100197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172697/
https://www.ncbi.nlm.nih.gov/pubmed/37181100
http://dx.doi.org/10.1016/j.prdoa.2023.100197

Ejemplares similares